Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, STIFEL FINANCIAL CORP insiders sold a net $372.2K of stock across 34 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Nobody has filed for crossing 5%. That is a fact, not missing data.
SF planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Brown Maryam S.
Filed 2026-07-23
$377.1K
Executive pay vs shareholder return · Ronald J. Kruszewski
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$18.9M
$42.8M
$8.1M
+171%
+81%
2024
$16.1M
$36.4M
$6.0M
+126%
+73%
2023
$13.3M
$18.0M
$5.7M
+44%
+33%
2022
$12.9M
$8.9M
$5.6M
+20%
+20%
2021
$13.6M
$24.5M
$7.2M
+41%
+42%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $372.2K sold by insiders over 180 days, 3 House member(s) bought in 12 months, disclosed weeks after the trade. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$6.7B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM SF
FY Dec 2025
$6.3B
FY Dec 2024
$6.0B
FY Dec 2023
$5.2B
FY Dec 2022
$4.6B
FY Dec 2021
$4.8B
Jun 2026
$1.6B
Mar 2026
$1.7B
Dec 2025
$1.8B
Sep 2025
$1.6B
Jun 2025
$1.5B
Mar 2025
$1.5B
Dec 2024
$1.6B
Sep 2024
$1.5B
At each fiscal year end
Single quarter
Net margin, TTM
+13.7%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM SF
FY Dec 2025
+10.2%
FY Dec 2024
+11.7%
FY Dec 2023
+9.4%
FY Dec 2022
+13.6%
FY Dec 2021
+16.5%
Jun 2026
+13.8%
Mar 2026
+15.1%
Dec 2025
+13.0%
Sep 2025
+12.9%
Jun 2025
+10.4%
Mar 2025
+3.6%
Dec 2024
+13.0%
Sep 2024
+10.7%
At each fiscal year end
Single quarter
Free cash flow, TTM
$361.0M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM SF
FY Dec 2025
$1.1B
FY Dec 2024
$416.6M
FY Dec 2023
$447.4M
FY Dec 2022
$1.1B
FY Dec 2021
$683.9M
Jun 2026
$61.3M
Mar 2026
-$390.4M
Dec 2025
$369.0M
Sep 2025
$321.1M
Jun 2025
$592.7M
Mar 2025
-$227.8M
Dec 2024
$406.4M
Sep 2024
$186.6M
At each fiscal year end
Single quarter
Debt to equity
0.14x
long-term 2026-06-30 plus current 2020-03-31 (76 months older than the period end); equity 2026-06-30
Debt to equity SF
FY Dec 2025
0.14x
FY Dec 2024
0.14x
FY Dec 2023
0.25x
FY Dec 2022
0.25x
FY Dec 2021
0.26x
Jun 2026
0.14x
Mar 2026
0.14x
Dec 2025
0.14x
Sep 2025
0.14x
Jun 2025
0.15x
Mar 2025
0.15x
Dec 2024
0.14x
Sep 2024
0.15x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.56x
TTM operating cash flow over long-term 2026-06-30 plus current 2020-03-31 (76 months older than the period end)
Cash flow to debt SF
FY Dec 2025
1.37x
FY Dec 2024
0.60x
FY Dec 2023
0.38x
FY Dec 2022
0.88x
FY Dec 2021
0.66x
Jun 2026
0.56x
Mar 2026
1.21x
Dec 2025
1.37x
Sep 2025
1.42x
Jun 2025
1.25x
Mar 2025
1.09x
Dec 2024
0.60x
Sep 2024
0.42x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+15.8%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity SF
FY Dec 2025
+11.1%
FY Dec 2024
+12.6%
FY Dec 2023
+9.1%
FY Dec 2022
+12.1%
FY Dec 2021
+17.0%
Jun 2026
+15.8%
Mar 2026
+14.7%
Dec 2025
+11.1%
Sep 2025
+11.1%
Jun 2025
+10.4%
Mar 2025
+10.8%
Dec 2024
+12.6%
Sep 2024
+11.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+2.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets SF
FY Dec 2025
+1.6%
FY Dec 2024
+1.8%
FY Dec 2023
+1.3%
FY Dec 2022
+1.8%
FY Dec 2021
+2.6%
Jun 2026
+2.2%
Mar 2026
+2.0%
Dec 2025
+1.6%
Sep 2025
+1.6%
Jun 2025
+1.5%
Mar 2025
+1.5%
Dec 2024
+1.8%
Sep 2024
+1.6%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital SF
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed SF
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
9.57x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing SF
FY Dec 2025
15.75x
FY Dec 2024
11.33x
FY Dec 2023
10.80x
FY Dec 2022
7.31x
FY Dec 2021
7.05x
Jun 2026
10.01x
Mar 2026
11.34x
Dec 2025
15.75x
Sep 2025
14.89x
Jun 2025
15.11x
Mar 2025
12.32x
Dec 2024
11.33x
Sep 2024
11.34x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$3.3B
market value at close 2026-10-23 on 2019-08-01 shares, plus long-term 2026-06-30 plus current 2020-03-31 (76 months older than the period end), minus cash 2026-06-30
Enterprise value SF
FY Dec 2025
$4.4B
FY Dec 2024
$3.1B
FY Dec 2023
$1.2B
FY Dec 2022
$1.8B
FY Dec 2021
$2.6B
Jun 2026
$3.5B
Mar 2026
$3.1B
Dec 2025
$4.4B
Sep 2025
$2.9B
Jun 2025
$3.8B
Mar 2025
$2.5B
Dec 2024
$3.1B
Sep 2024
$3.3B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+7.8%
TTM free cash flow over market value at close 2026-10-23
FCF yield SF
FY Dec 2025
+18.2%
FY Dec 2024
+8.5%
FY Dec 2023
+13.9%
FY Dec 2022
+39.7%
FY Dec 2021
+20.9%
Jun 2026
+7.4%
Mar 2026
+17.3%
Dec 2025
+18.2%
Sep 2025
+20.8%
Jun 2025
+19.9%
Mar 2025
+18.5%
Dec 2024
+8.5%
Sep 2024
+6.3%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.18x
P/E over trailing EPS growth of 52%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing SF
FY Dec 2025
n/a
FY Dec 2024
0.25x
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
0.12x
Jun 2026
0.19x
Mar 2026
0.41x
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
0.76x
Dec 2024
0.25x
Sep 2024
0.41x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
SF ranks highest on financial health (72nd percentile) and institutional and government (67th), and lowest on insider conviction (28th), among Financial Services peers.
Profitability
64
Inputs
Return on equity+15.8% · 66 pct, sector of 205
Return on assets+2.2% · 62 pct, sector of 266
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
72
Inputs
Debt to equity0.14x · 66 pct, sector of 181
Cash flow to debt0.56x · 78 pct, sector of 141
Growth
55
Inputs
Revenue growth, YoY+14.5% · 55 pct, sector of 245
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
28
Inputs
Net Form 4 buying (codes P and S), 180d-$372K · 57 pct, sector of 161
Insider buyers, 180d0 · 0 pct, sector of 165
Institutional and government
67
Inputs
Funds adding, latest quarterfewer than five funds report holding it
Congress net buyers, 365d1 · 67 pct, sector of 31
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
51
Inputs
Short interest, % of float+3.0% · 54 pct, sector of 390
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+13.4% · 48 pct, sector of 175
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
SF filings, in plain words
Are Stifel Financial insiders buying or selling SF?
In the 180 days to 2026-10-27, Stifel Financial insiders were net sellers, a net $372.2K across purchases and sales reported on Form 4, by 1 seller.
Have members of Congress traded SF?
Yes. In the year to 2026-10-27, 3 House members disclosed buying SF and 2 House members disclosed selling it; the latest on record is a purchase by Gilbert Cisneros dated 2026-07-10.
Read the full summary
In the 180 days to 2026-10-27, Stifel Financial insiders were net sellers of SF, a net $372.2K across purchases and sales reported on Form 4 by 1 seller. In the year to 2026-10-27, 3 members of Congress disclosed buying SF and 2 members disclosed selling it; the latest on record is a purchase by Gilbert Cisneros dated 2026-07-10. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.